Bayer AG Bayer Bitterfeld GmbH Bayer HealthCare Manufacturing S.r.l.
PolandAll drugs from this manufacturer
-
The medicine is used in adults to reduce the risk of a subsequent heart attack or death due to cardiovascular disease (in patients with acute coronary syndrome) and to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
It is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery. It also helps in the treatment of deep vein thrombosis and pulmonary embolism and prevents their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg veins and lungs. In children and adolescents (over 30 kg), it is also used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots after initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01